Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Single Dose vs Short-Term Peri-Operative Cefazolin in Orthognathic Surgery
NCT05852158Phase 4Recruiting
- Start
- Jan 2024
- Primary completion
- Jan 2027
- Modality
- Reversible Covalent Inhibitors
- Countries
- 1
01
Overview
A Phase 4 trial of cefazolin in surgical site infection (SSI). Started Jan 2024; status: recruiting.
02
Drugs
cefazolin
03
Conditions
surgical site infection (SSI)
Beyond the preview
Go deeper on NCT05852158.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT05852158.